Metoprolol Succinate Tablet, Extended Release
Product Images NDC 50742-616

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 50742-616). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

Chemical structure diagram showing two components: the left portion depicts the molecular structure of metoprolol succinate, and the right portion represents succinic acid, indicating the combined structure of metoprolol succinate.*

FDA Label Image

Image-02 (Image 02)

A results chart from the MERIT-HF study showing relative risk and 95% confidence intervals for different subgroups. It compares Metoprolol Succinate Extended-Release Tablets versus placebo on outcomes including total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. Subgroups include geographic region, NYHA class, ejection fraction, etiology, sex, race, myocardial infarction history, diabetes status, hypertension, and heart rate.*

FDA Label Image

Image-03 (Image 03)

FDA Label Image

Image-04 (Image 04)

Metoprolol Succinate Extended-Release Tablets, USP 25 mg by Ingenus Pharmaceuticals, LLC. The oral tablet packaging is labeled for prescription use only, contains 100 tablets, and includes dosage information indicating each tablet has 23.75 mg metoprolol succinate equivalent to 25 mg metoprolol tartrate. The label specifies storage instructions at 20° to 25°C (68° to 77°F).*

FDA Label Image

Image-05 (Image 05)

Metoprolol Succinate Extended-Release Tablets, USP 50 mg, oral dosage form by Ingenus Pharmaceuticals, LLC. The label indicates 100 tablets per package with NDC 50742-616-01, including storage instructions and warnings. The label also displays batch details and expiration date.*

FDA Label Image

Image-06 (Image 06)

Metoprolol Succinate Extended-Release Tablets, USP 100 mg by Ingenus Pharmaceuticals, LLC. This Rx-only package contains 100 tablets. The label includes dosage information, storage instructions, a barcode, lot number, and expiration date.*

FDA Label Image

Image-07 (Image 07)

Metoprolol Succinate Extended-Release Tablets, USP 200 mg, oral tablets by Ingenus Pharmaceuticals, LLC. The label indicates 100 tablets per bottle, Rx only. It includes dosage strength, manufacturer details, storage instructions, warnings, NDC 50742-618-01, lot number, expiration date, and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.